BOSTON--(BUSINESS WIRE)--Jan 3, 2023--

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that Bill Meury, president and chief executive officer, will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 9:00 a.m. PST (12:00 p.m. EST).

A live webcast of the presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna’s website following the conference.

About Karuna

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20230103005169/en/

CONTACT: Investor Contact:

Alexis Smith

518-338-8990

asmith@karunatx.comMedia Contact:

Bob Josefsberg

bjosefsberg@karunatx.com

646-734-3584

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: BIOTECHNOLOGY NEUROLOGY OTHER HEALTH HEALTH PHARMACEUTICAL

SOURCE: Karuna Therapeutics, Inc.

Copyright Business Wire 2023.

PUB: 01/03/2023 06:30 AM/DISC: 01/03/2023 06:30 AM

http://www.businesswire.com/news/home/20230103005169/en